Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Minocin 50mg tablets
0501030P0BBAAAA
|
Minocin | Minocycline hydrochloride | Infections | No data available |
|
Minocycline 50mg/5ml oral liquid
0501030P0AAAFAF
|
Minocycline hydrochloride (Systemic) | Minocycline hydrochloride | Infections | No data available |
|
Monotrim 100mg tablets
0501080W0BCAAAD
|
Monotrim | Trimethoprim | Infections | No data available |
|
Monotrim 100mg/5ml solution for injection ampoules
0501080W0BCADAA
|
Monotrim | Trimethoprim | Infections | No data available |
|
Monotrim 200mg tablets
0501080W0BCABAE
|
Monotrim | Trimethoprim | Infections | No data available |
|
Monotrim 50mg/5ml oral suspension
0501080W0BCACAI
|
Monotrim | Trimethoprim | Infections | No data available |
|
Monurol 3g granules for oral solution sachets
0501070AEBCAAAD
|
Monurol | Fosfomycin trometamol | Infections | No data available |
|
Moxifloxacin 400mg/250ml infusion bags
0501120Y0AAACAC
|
Moxifloxacin | Moxifloxacin | Infections | No data available |
|
Moxifloxacin 400mg/250ml solution for infusion bottles
0501120Y0AAABAB
|
Moxifloxacin | Moxifloxacin | Infections | No data available |
|
Moxifloxacin 400mg/5ml oral solution
0501120Y0AAADAD
|
Moxifloxacin | Moxifloxacin | Infections | No data available |
|
Munuza 300mg/5ml nebuliser solution 5ml ampoules
0501040U0BHAAAG
|
Munuza | Tobramycin | Infections | No data available |
|
Mycamine 100mg powder for solution for infusion vials
0502040B0BBAAAA
|
Mycamine | Micafungin | Infections | No data available |
|
Mycamine 50mg powder for solution for infusion vials
0502040B0BBABAB
|
Mycamine | Micafungin | Infections | No data available |
|
Mycifor XL 500mg tablets
0501050B0BFAAAE
|
Mycifor | Clarithromycin | Infections | No data available |
|
Nalidixic acid 300mg/5ml oral suspension
0501120N0AAAAAA
|
Nalidixic acid | Nalidixic acid | Infections | No data available |
|
Nalidixic acid 300mg/5ml oral suspension sugar free
0501120N0AAAFAF
|
Nalidixic acid | Nalidixic acid | Infections | No data available |
|
Nalidixic acid 500mg tablets
0501120N0AAABAB
|
Nalidixic acid | Nalidixic acid | Infections | No data available |
|
National 30 day HIV post exposure prophylaxis pack
0503010AYBBAAAA
|
National 30 day HIV | Raltegravir/Emtricitabine/Tenofovir disoproxil | Infections | No data available |
|
Nebcin 20mg/2ml solution for injection vials
0501040U0BBAAAA
|
Nebcin | Tobramycin | Infections | No data available |
|
Negaban 1g powder for solution for injection vials
0501012U0BCAAAB
|
Negaban | Temocillin sodium | Infections | No data available |
|
Negram 300mg/5ml oral suspension
0501120N0BBABAF
|
Negram | Nalidixic acid | Infections | No data available |
|
Negram 500mg tablets
0501120N0BBAAAB
|
Negram | Nalidixic acid | Infections | No data available |
|
Nelfinavir 250mg tablets
0503010C0AAAAAA
|
Nelfinavir mesilate | Nelfinavir mesilate | Infections | No data available |
|
Nelfinavir 50mg/g oral powder
0503010C0AAABAB
|
Nelfinavir mesilate | Nelfinavir mesilate | Infections | No data available |
|
Neomycin 100mg/5ml oral solution
0501040N0AAAJAJ
|
Neomycin sulfate (Systemic) | Neomycin sulfate | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.